Journal
MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 20, Issue -, Pages 661-672Publisher
CELL PRESS
DOI: 10.1016/j.omtn.2020.04.005
Keywords
-
Categories
Funding
- Bloomberg-Kimmel Institute for cancer immunotherapy
- Research to Prevent Blindness James and Carole Free Catalyst Award
- NSF [DGE-0707427, DGE-1232825]
- NIH [R01CA228133, R01EB022148]
- Microscopy Core [S10 OD016374]
- Wilmer Core [P30 EY001765]
Ask authors/readers for more resources
The CRISPR-Cas9 system is a powerful gene-editing tool with wide-ranging applications, but the safe and efficient intracellular delivery of CRISPR components remains a challenge. In this study, we utilized biodegradable poly(beta-amino ester) nanoparticles to codeliver plasmid DNA encoding Cas9 and short guide RNA (sgRNA), respectively, to enable gene knockout following a CRISPR-mediated cleavage at one genomic site (1-cut edit), as well as gene deletion following DNA cleavage at two sites flanking a region of interest (2-cut edits). We designed a reporter system that allows for easy evaluation of both types of edits: gene knockout can be assessed by a decrease in near-infrared fluorescent protein (iRFP) fluorescence, whereas deletion of an expression stop cassette turns on a red-enhanced nanolantern fluorescence/luminescence dual reporter. Nanoparticles enabled up to 70% gene knockout due to small indels, as well as 45% gain-of-function expression after a 600-bp deletion edit. The efficiency of 2-cut edits is more sensitive than 1-cut edits to Cas9 and the sgRNA expression level. We demonstrate promising biodegradable nanoparticle formulations for gene editing. Our findings also provide new insights into the screening and transfection requirements for different types of gene edits, which are applicable for designing nonviral delivery systems for the CRISPR-Cas9 platform.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available